Literature DB >> 18832704

Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis.

Stacy J Caillier1, Farren Briggs, Bruce A C Cree, Sergio E Baranzini, Marcelo Fernandez-Viña, Patricia P Ramsay, Omar Khan, Walter Royal, Stephen L Hauser, Lisa F Barcellos, Jorge R Oksenberg.   

Abstract

Genetic susceptibility to multiple sclerosis (MS) is associated with the MHC located on chromosome 6p21. This signal maps primarily to a 1-Mb region encompassing the HLA class II loci, and it segregates often with the HLA-DQB1*0602, -DQA1*0102, -DRB1*1501, -DRB5*0101 haplotype. However, the identification of the true predisposing gene or genes within the susceptibility haplotype has been handicapped by the strong linkage disequilibrium across the locus. African Americans have greater MHC haplotypic diversity and distinct patterns of linkage disequilibrium, which make this population particularly informative for fine mapping efforts. The purpose of this study was to establish the telomeric boundary of the HLA class II region affecting susceptibility to MS by assessing genetic association with the neighboring HLA-DRB5 gene as well as seven telomeric single nucleotide polymorphisms in a large, well-characterized African American dataset. Rare DRB5*null individuals were previously described in African populations. Although significant associations with both HLA-DRB1 and HLA-DRB5 loci were present, HLA-DRB1*1503 was associated with MS in the absence of HLA-DRB5, providing evidence for HLA-DRB1 as the primary susceptibility gene. Interestingly, the HLA-DRB5*null subjects appear to be at increased risk for developing secondary progressive MS. Thus, HLA-DRB5 attenuates MS severity, a finding consistent with HLA-DRB5's proposed role as a modifier in experimental autoimmune encephalomyelitis. Additionally, conditional haplotype analysis revealed a susceptibility signal at the class III AGER locus independent of DRB1. The data underscore the power of the African American MS dataset to identify disease genes by association in a region of high linkage disequilibrium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832704      PMCID: PMC4346327          DOI: 10.4049/jimmunol.181.8.5473

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Mapping candidate non-MHC susceptibility regions to multiple sclerosis.

Authors:  H Abdeen; S Heggarty; S A Hawkins; M Hutchinson; G V McDonnell; C A Graham
Journal:  Genes Immun       Date:  2006-07-13       Impact factor: 2.676

2.  HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus: application of the haplotype method.

Authors:  A M Valdes; S McWeeney; G Thomson
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

3.  Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis.

Authors:  B A C Cree; O Khan; D Bourdette; D S Goodin; J A Cohen; R A Marrie; D Glidden; B Weinstock-Guttman; D Reich; N Patterson; J L Haines; M Pericak-Vance; C DeLoa; J R Oksenberg; S L Hauser
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

4.  HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice.

Authors:  Meenakshi Khare; Ashutosh Mangalam; Moses Rodriguez; Chella S David
Journal:  J Neuroimmunol       Date:  2005-09-27       Impact factor: 3.478

5.  DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.

Authors:  O Fernández; V Fernández; A Alonso; A Caballero; G Luque; M Bravo; A León; C Mayorga; L Leyva; E de Ramón
Journal:  J Neurol       Date:  2004-04       Impact factor: 4.849

6.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

Authors:  Heather L E Lang; Helle Jacobsen; Shinji Ikemizu; Christina Andersson; Karl Harlos; Lars Madsen; Peter Hjorth; Leif Sondergaard; Arne Svejgaard; Kai Wucherpfennig; David I Stuart; John I Bell; E Yvonne Jones; Lars Fugger
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

7.  RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response.

Authors:  M A Hofmann; S Drury; B I Hudson; M R Gleason; W Qu; Y Lu; E Lalla; S Chitnis; J Monteiro; M H Stickland; L G Bucciarelli; B Moser; G Moxley; S Itescu; P J Grant; P K Gregersen; D M Stern; A M Schmidt
Journal:  Genes Immun       Date:  2002-05       Impact factor: 2.676

8.  Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.

Authors:  E Quelvennec; O Bera; P Cabre; M Alizadeh; D Smadja; F Jugde; G Edan; G Semana
Journal:  Tissue Antigens       Date:  2003-02

9.  Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.

Authors:  Nobuyuki Sasaki; Masayoshi Takeuchi; Hiroshi Chowei; Seiji Kikuchi; Yorihide Hayashi; Norihito Nakano; Hiroshi Ikeda; Sho-ichi Yamagishi; Tetsuyuki Kitamoto; Toshikazu Saito; Zenji Makita
Journal:  Neurosci Lett       Date:  2002-06-28       Impact factor: 3.046

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  41 in total

Review 1.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

Review 2.  The genetics of multiple sclerosis: an up-to-date review.

Authors:  Pierre-Antoine Gourraud; Hanne F Harbo; Stephen L Hauser; Sergio E Baranzini
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the future.

Authors:  Philip L De Jager
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

Review 4.  From genes to function: the next challenge to understanding multiple sclerosis.

Authors:  Lars Fugger; Manuel A Friese; John I Bell
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

5.  Variation within DNA repair pathway genes and risk of multiple sclerosis.

Authors:  Farren B S Briggs; Benjamin A Goldstein; Jacob L McCauley; Rebecca L Zuvich; Philip L De Jager; John D Rioux; Adrian J Ivinson; Alastair Compston; David A Hafler; Stephen L Hauser; Jorge R Oksenberg; Stephen J Sawcer; Margaret A Pericak-Vance; Jonathan L Haines; Lisa F Barcellos
Journal:  Am J Epidemiol       Date:  2010-06-03       Impact factor: 4.897

6.  CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis.

Authors:  Paola G Bronson; Stacy Caillier; Patricia P Ramsay; Jacob L McCauley; Rebecca L Zuvich; Philip L De Jager; John D Rioux; Adrian J Ivinson; Alastair Compston; David A Hafler; Stephen J Sawcer; Margaret A Pericak-Vance; Jonathan L Haines; Stephen L Hauser; Jorge R Oksenberg; Lisa F Barcellos
Journal:  Hum Mol Genet       Date:  2010-03-08       Impact factor: 6.150

7.  Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis.

Authors:  Jacqueline A Quandt; Jaebong Huh; Mirza Baig; Karen Yao; Naoko Ito; Mark Bryant; Kazuyuki Kawamura; Clemencia Pinilla; Henry F McFarland; Roland Martin; Kouichi Ito
Journal:  J Immunol       Date:  2012-08-10       Impact factor: 5.422

8.  Genetic risk variants in African Americans with multiple sclerosis.

Authors:  Noriko Isobe; Pierre-Antoine Gourraud; Hanne F Harbo; Stacy J Caillier; Adam Santaniello; Pouya Khankhanian; Martin Maiers; Stephen Spellman; Nezih Cereb; SooYoung Yang; Marcelo J Pando; Laura Piccio; Anne H Cross; Philip L De Jager; Bruce A C Cree; Stephen L Hauser; Jorge R Oksenberg
Journal:  Neurology       Date:  2013-06-14       Impact factor: 9.910

9.  Copy number variation in African Americans.

Authors:  Joseph P McElroy; Matthew R Nelson; Stacy J Caillier; Jorge R Oksenberg
Journal:  BMC Genet       Date:  2009-03-24       Impact factor: 2.797

10.  Multiple sclerosis susceptibility alleles in African Americans.

Authors:  B A Johnson; J Wang; E M Taylor; S J Caillier; J Herbert; O A Khan; A H Cross; P L De Jager; P-A F Gourraud; B C A Cree; S L Hauser; J R Oksenberg
Journal:  Genes Immun       Date:  2009-10-29       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.